

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.60001260 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.34505242 |
| 3 | cytidine deamination (GO:0009972) | 5.21954786 |
| 4 | cytidine metabolic process (GO:0046087) | 5.21954786 |
| 5 | cytidine catabolic process (GO:0006216) | 5.21954786 |
| 6 | leukocyte aggregation (GO:0070486) | 4.94915922 |
| 7 | negative thymic T cell selection (GO:0045060) | 4.82382033 |
| 8 | DNA deamination (GO:0045006) | 4.76025583 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.72535036 |
| 10 | negative T cell selection (GO:0043383) | 4.71278018 |
| 11 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.63658361 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.58818052 |
| 13 | T cell migration (GO:0072678) | 4.52376211 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.45731473 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45731473 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.38843291 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.38843291 |
| 18 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.36247043 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.31023463 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.23283526 |
| 21 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.16366764 |
| 22 | neutrophil activation (GO:0042119) | 4.06444120 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.99138848 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 3.91938326 |
| 25 | granulocyte activation (GO:0036230) | 3.88600166 |
| 26 | response to interferon-beta (GO:0035456) | 3.85000788 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.84592126 |
| 28 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.80967822 |
| 29 | respiratory burst (GO:0045730) | 3.79865111 |
| 30 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.71615543 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.71369898 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.69430651 |
| 33 | NIK/NF-kappaB signaling (GO:0038061) | 3.69317727 |
| 34 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.66888233 |
| 35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.65571092 |
| 36 | thymic T cell selection (GO:0045061) | 3.65353791 |
| 37 | negative regulation of T cell apoptotic process (GO:0070233) | 3.63256962 |
| 38 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.58451603 |
| 39 | cellular response to zinc ion (GO:0071294) | 3.45997484 |
| 40 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.45698362 |
| 41 | * sequestering of actin monomers (GO:0042989) | 3.45205587 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.44997373 |
| 43 | T cell costimulation (GO:0031295) | 3.44620813 |
| 44 | response to interleukin-15 (GO:0070672) | 3.42615134 |
| 45 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.42235857 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.41850124 |
| 47 | lymphocyte costimulation (GO:0031294) | 3.41641806 |
| 48 | myeloid dendritic cell differentiation (GO:0043011) | 3.39204614 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38516433 |
| 50 | mast cell activation (GO:0045576) | 3.38292124 |
| 51 | myeloid dendritic cell activation (GO:0001773) | 3.37696565 |
| 52 | T cell selection (GO:0045058) | 3.37027973 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.34319226 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.34319226 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 3.33517005 |
| 56 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.32071575 |
| 57 | leukocyte cell-cell adhesion (GO:0007159) | 3.32029071 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.32026509 |
| 59 | response to type I interferon (GO:0034340) | 3.30916750 |
| 60 | positive regulation of interleukin-2 production (GO:0032743) | 3.27964757 |
| 61 | response to peptidoglycan (GO:0032494) | 3.26772737 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25056833 |
| 63 | negative regulation of viral genome replication (GO:0045071) | 3.24523811 |
| 64 | lymphocyte migration (GO:0072676) | 3.23747399 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.22804197 |
| 66 | positive regulation of cell killing (GO:0031343) | 3.22183363 |
| 67 | regulation of tolerance induction (GO:0002643) | 3.22158911 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.22143399 |
| 69 | actin nucleation (GO:0045010) | 3.20806304 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.20704473 |
| 71 | B cell mediated immunity (GO:0019724) | 3.19914248 |
| 72 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19288035 |
| 73 | regulation of cell killing (GO:0031341) | 3.19027888 |
| 74 | positive regulation by symbiont of host defense response (GO:0052509) | 3.17926189 |
| 75 | modulation by symbiont of host defense response (GO:0052031) | 3.17926189 |
| 76 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.17926189 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.17926189 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.17926189 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 3.17926189 |
| 80 | regulation of B cell differentiation (GO:0045577) | 3.17805391 |
| 81 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.16234236 |
| 82 | lymphocyte chemotaxis (GO:0048247) | 3.15175786 |
| 83 | positive regulation of lamellipodium assembly (GO:0010592) | 3.14689136 |
| 84 | regulation of gamma-delta T cell activation (GO:0046643) | 3.14594867 |
| 85 | interferon-gamma production (GO:0032609) | 3.12376475 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 3.12037991 |
| 87 | positive regulation of macrophage differentiation (GO:0045651) | 3.11450917 |
| 88 | membrane raft organization (GO:0031579) | 3.09714409 |
| 89 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.06770896 |
| 90 | tolerance induction (GO:0002507) | 3.06030496 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.05415972 |
| 92 | natural killer cell activation (GO:0030101) | 3.03250907 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 3.02465780 |
| 94 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01887928 |
| 95 | positive regulation of defense response to virus by host (GO:0002230) | 3.01663820 |
| 96 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.01537557 |
| 97 | positive T cell selection (GO:0043368) | 3.01018768 |
| 98 | regulation of hypersensitivity (GO:0002883) | 2.97933630 |
| 99 | cellular extravasation (GO:0045123) | 2.97926568 |
| 100 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.97614784 |
| 101 | leukocyte degranulation (GO:0043299) | 2.97209529 |
| 102 | cellular defense response (GO:0006968) | 2.96148450 |
| 103 | cellular response to interferon-beta (GO:0035458) | 2.96054889 |
| 104 | positive regulation of isotype switching (GO:0045830) | 2.95858009 |
| 105 | positive regulation of interleukin-12 production (GO:0032735) | 2.93895569 |
| 106 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.93659928 |
| 107 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.93449061 |
| 108 | natural killer cell mediated immunity (GO:0002228) | 2.93449061 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.93357514 |
| 110 | T cell receptor signaling pathway (GO:0050852) | 2.92371418 |
| 111 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.92243541 |
| 112 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.92038993 |
| 113 | regulation of interferon-alpha production (GO:0032647) | 2.91481652 |
| 114 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.91076837 |
| 115 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90743004 |
| 116 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90743004 |
| 117 | B cell receptor signaling pathway (GO:0050853) | 2.87079308 |
| 118 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.86588413 |
| 119 | regulation of T cell apoptotic process (GO:0070232) | 2.84923210 |
| 120 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.83955436 |
| 121 | positive regulation of mast cell activation (GO:0033005) | 2.82486137 |
| 122 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.82384311 |
| 123 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.82345570 |
| 124 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.81739280 |
| 125 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80910380 |
| 126 | leukocyte mediated cytotoxicity (GO:0001909) | 2.80857613 |
| 127 | dendritic cell differentiation (GO:0097028) | 2.80809188 |
| 128 | defense response to protozoan (GO:0042832) | 2.80213264 |
| 129 | myeloid leukocyte activation (GO:0002274) | 2.79481586 |
| 130 | positive regulation of tolerance induction (GO:0002645) | 2.79304927 |
| 131 | dendritic cell chemotaxis (GO:0002407) | 2.78330885 |
| 132 | T cell proliferation (GO:0042098) | 2.78093520 |
| 133 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.78005261 |
| 134 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.77458904 |
| 135 | positive regulation of T cell mediated immunity (GO:0002711) | 2.77338828 |
| 136 | regulation of activation of Janus kinase activity (GO:0010533) | 2.75630955 |
| 137 | negative regulation of stress fiber assembly (GO:0051497) | 2.74234210 |
| 138 | regulation of defense response to virus by virus (GO:0050690) | 2.73823111 |
| 139 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.73452970 |
| 140 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.72824901 |
| 141 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.72718063 |
| 142 | mast cell degranulation (GO:0043303) | 2.69014921 |
| 143 | mast cell activation involved in immune response (GO:0002279) | 2.69014921 |
| 144 | detection of bacterium (GO:0016045) | 2.68035095 |
| 145 | negative regulation of interleukin-12 production (GO:0032695) | 2.64687749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.68572927 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.41906683 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.15479084 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.89756488 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.59850703 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.42700411 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.94652325 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.70475967 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.65195568 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.65133731 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.58747996 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.35072425 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30426503 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06929418 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.81858215 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.71500786 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66953644 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.64131198 |
| 19 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.47841517 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.43530949 |
| 21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.42299525 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.39352673 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21104562 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.20755705 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.11523510 |
| 26 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10322942 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 1.91981728 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89186218 |
| 29 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.81855838 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81405551 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.80020559 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79647543 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79634267 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77501747 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75600534 |
| 36 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.75178890 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73031232 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71669718 |
| 39 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.71261469 |
| 40 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70425046 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65376609 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.64270179 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60592674 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.60125870 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58675100 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58390174 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56496221 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.55961258 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53911608 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53146529 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.52457503 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49027790 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45623730 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45544647 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39330414 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39231986 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38717925 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37882748 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37562682 |
| 60 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.33921562 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31258098 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30789829 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.29824981 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23615328 |
| 65 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22060471 |
| 66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.20372889 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.19448376 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19401585 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18203291 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17962585 |
| 71 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.16416662 |
| 72 | MYC_22102868_ChIP-Seq_BL_Human | 1.15692227 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15572889 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15016262 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14804638 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14171898 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.12906390 |
| 78 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12153885 |
| 79 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.10228359 |
| 80 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.09757444 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09174484 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07044577 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06446066 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04536574 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04526488 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03972968 |
| 87 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03012907 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02895555 |
| 89 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02459354 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02190915 |
| 91 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01084113 |
| 92 | * P300_27268052_Chip-Seq_Bcells_Human | 1.00741398 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00021787 |
| 94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99525521 |
| 95 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98422923 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97637380 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94616938 |
| 98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94272601 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94212914 |
| 100 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.93505240 |
| 101 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93310526 |
| 102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91485124 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90945226 |
| 104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90723036 |
| 105 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.90036994 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89586166 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88976278 |
| 108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88735902 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88644538 |
| 110 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88157107 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88123674 |
| 112 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87001351 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85377334 |
| 114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84798475 |
| 115 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83886647 |
| 116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.83496258 |
| 117 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82247910 |
| 118 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.81805547 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81308574 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81000628 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79630327 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74539571 |
| 123 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.72635356 |
| 124 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.72333303 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72283824 |
| 126 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.71834406 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69125144 |
| 128 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.68107117 |
| 129 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.66943445 |
| 130 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.66784484 |
| 131 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.66638953 |
| 132 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.66607761 |
| 133 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65922578 |
| 134 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.63636426 |
| 135 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.61712436 |
| 136 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.61491589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.99792983 |
| 2 | MP0005671_abnormal_response_to | 4.13407067 |
| 3 | MP0009785_altered_susceptibility_to | 3.77825226 |
| 4 | MP0000685_abnormal_immune_system | 3.67654157 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.41846597 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.38719733 |
| 7 | MP0003436_decreased_susceptibility_to | 3.30086250 |
| 8 | MP0001790_abnormal_immune_system | 3.29989052 |
| 9 | MP0005387_immune_system_phenotype | 3.29989052 |
| 10 | MP0006082_CNS_inflammation | 3.16403542 |
| 11 | MP0005025_abnormal_response_to | 3.01390111 |
| 12 | MP0001800_abnormal_humoral_immune | 2.96215921 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.86514667 |
| 14 | MP0002723_abnormal_immune_serum | 2.82927616 |
| 15 | MP0002419_abnormal_innate_immunity | 2.82416854 |
| 16 | MP0001819_abnormal_immune_cell | 2.77849437 |
| 17 | MP0004510_myositis | 2.77163104 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.76918173 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.73268685 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.72222627 |
| 21 | MP0003303_peritoneal_inflammation | 2.48566504 |
| 22 | MP0002006_tumorigenesis | 2.47404540 |
| 23 | MP0003724_increased_susceptibility_to | 2.42117619 |
| 24 | MP0002405_respiratory_system_inflammati | 2.31638347 |
| 25 | MP0000716_abnormal_immune_system | 2.09155288 |
| 26 | MP0002398_abnormal_bone_marrow | 2.07771380 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.96239621 |
| 28 | MP0005310_abnormal_salivary_gland | 1.92832776 |
| 29 | MP0001853_heart_inflammation | 1.83023119 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.81518957 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.80270564 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.77211915 |
| 33 | MP0004947_skin_inflammation | 1.76643302 |
| 34 | MP0003448_altered_tumor_morphology | 1.75139645 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.72047820 |
| 36 | MP0000858_altered_metastatic_potential | 1.64172589 |
| 37 | MP0002429_abnormal_blood_cell | 1.61921871 |
| 38 | MP0002722_abnormal_immune_system | 1.58606863 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.55756371 |
| 40 | MP0001873_stomach_inflammation | 1.53581346 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.52452054 |
| 42 | MP0002933_joint_inflammation | 1.50264484 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.47187217 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.43688948 |
| 45 | MP0008469_abnormal_protein_level | 1.36076471 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.32761374 |
| 47 | MP0009764_decreased_sensitivity_to | 1.32069933 |
| 48 | MP0000343_altered_response_to | 1.30424458 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.28512696 |
| 50 | MP0002163_abnormal_gland_morphology | 1.26523214 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.24428222 |
| 52 | MP0003866_abnormal_defecation | 1.21059916 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.18846139 |
| 54 | MP0006054_spinal_hemorrhage | 1.09359719 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.05265204 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.05074854 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.04061893 |
| 58 | MP0000604_amyloidosis | 1.02400350 |
| 59 | MP0002009_preneoplasia | 1.02291124 |
| 60 | MP0001851_eye_inflammation | 1.01561001 |
| 61 | MP0005166_decreased_susceptibility_to | 0.95634951 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 0.89970956 |
| 63 | MP0003075_altered_response_to | 0.89650352 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 0.89049379 |
| 65 | MP0002653_abnormal_ependyma_morphology | 0.87667589 |
| 66 | MP0002254_reproductive_system_inflammat | 0.86035280 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 0.85986548 |
| 68 | MP0001905_abnormal_dopamine_level | 0.84215724 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.84054791 |
| 70 | MP0003091_abnormal_cell_migration | 0.83457186 |
| 71 | MP0003045_fibrosis | 0.82366452 |
| 72 | MP0000920_abnormal_myelination | 0.81794435 |
| 73 | MP0000249_abnormal_blood_vessel | 0.80090418 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.79267961 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.78784950 |
| 76 | MP0005165_increased_susceptibility_to | 0.76636490 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.76195123 |
| 78 | MP0003011_delayed_dark_adaptation | 0.75148676 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.73880783 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.73880783 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 0.73364427 |
| 82 | MP0001958_emphysema | 0.70548627 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.69827046 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.69407092 |
| 85 | MP0005164_abnormal_response_to | 0.69101536 |
| 86 | MP0009763_increased_sensitivity_to | 0.68517811 |
| 87 | MP0003329_amyloid_beta_deposits | 0.68402674 |
| 88 | MP0005390_skeleton_phenotype | 0.68279959 |
| 89 | MP0009840_abnormal_foam_cell | 0.67686651 |
| 90 | MP0004883_abnormal_blood_vessel | 0.67476053 |
| 91 | MP0008872_abnormal_physiological_respon | 0.66855270 |
| 92 | MP0008874_decreased_physiological_sensi | 0.66346874 |
| 93 | MP0001346_abnormal_lacrimal_gland | 0.66206235 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.64384570 |
| 95 | MP0002132_abnormal_respiratory_system | 0.62604366 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.61170455 |
| 97 | MP0008004_abnormal_stomach_pH | 0.60993726 |
| 98 | MP0001663_abnormal_digestive_system | 0.60873188 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.60714668 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.60114993 |
| 101 | MP0003795_abnormal_bone_structure | 0.59825250 |
| 102 | MP0003786_premature_aging | 0.59665083 |
| 103 | MP0006036_abnormal_mitochondrial_physio | 0.58933856 |
| 104 | MP0009278_abnormal_bone_marrow | 0.58122346 |
| 105 | MP0005083_abnormal_biliary_tract | 0.57872500 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.56349092 |
| 107 | MP0000490_abnormal_crypts_of | 0.56159003 |
| 108 | MP0001919_abnormal_reproductive_system | 0.55833179 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55518550 |
| 110 | MP0003638_abnormal_response/metabolism_ | 0.55058486 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.53782876 |
| 112 | MP0001542_abnormal_bone_strength | 0.52615786 |
| 113 | MP0003279_aneurysm | 0.51417704 |
| 114 | MP0002102_abnormal_ear_morphology | 0.50880646 |
| 115 | MP0003186_abnormal_redox_activity | 0.49877338 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.49454692 |
| 117 | MP0002735_abnormal_chemical_nociception | 0.48647342 |
| 118 | MP0003828_pulmonary_edema | 0.48422134 |
| 119 | MP0005023_abnormal_wound_healing | 0.47092263 |
| 120 | MP0008260_abnormal_autophagy | 0.46695792 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.46647566 |
| 122 | MP0001881_abnormal_mammary_gland | 0.45210335 |
| 123 | MP0001879_abnormal_lymphatic_vessel | 0.44790504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.52860056 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.43988846 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.47433264 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.46554673 |
| 5 | Myositis (HP:0100614) | 4.80636303 |
| 6 | Increased IgM level (HP:0003496) | 4.71640426 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.48239256 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.35761320 |
| 9 | Optic neuritis (HP:0100653) | 4.30548179 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.30548179 |
| 11 | Stomatitis (HP:0010280) | 4.28210512 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.22946571 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.18483727 |
| 14 | Abnormality of T cell number (HP:0011839) | 4.13711711 |
| 15 | Orchitis (HP:0100796) | 4.12257115 |
| 16 | Recurrent skin infections (HP:0001581) | 4.09311786 |
| 17 | Obstructive lung disease (HP:0006536) | 4.06189654 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.06189654 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.89617832 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.89617832 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.86494964 |
| 22 | Vasculitis (HP:0002633) | 3.82308276 |
| 23 | T lymphocytopenia (HP:0005403) | 3.81608172 |
| 24 | Chronic otitis media (HP:0000389) | 3.64760380 |
| 25 | Gingivitis (HP:0000230) | 3.53219893 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.46219928 |
| 27 | Recurrent viral infections (HP:0004429) | 3.42813180 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.36011782 |
| 29 | Hypergammaglobulinemia (HP:0010702) | 3.35293924 |
| 30 | Abnormality of B cell number (HP:0010975) | 3.32181387 |
| 31 | Aplastic anemia (HP:0001915) | 3.30162669 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.29415401 |
| 33 | Meningitis (HP:0001287) | 3.27124124 |
| 34 | IgM deficiency (HP:0002850) | 3.21859652 |
| 35 | Abnormality of T cells (HP:0002843) | 3.19578652 |
| 36 | Leukocytosis (HP:0001974) | 3.17364204 |
| 37 | Combined immunodeficiency (HP:0005387) | 3.14323066 |
| 38 | Nasal polyposis (HP:0100582) | 3.10902846 |
| 39 | IgG deficiency (HP:0004315) | 3.10057446 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.06860802 |
| 41 | Pustule (HP:0200039) | 3.04772853 |
| 42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.03675122 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.97174123 |
| 44 | Hemoptysis (HP:0002105) | 2.94772662 |
| 45 | Thyroiditis (HP:0100646) | 2.94233356 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.87877198 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 2.85260379 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.82886297 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.79709551 |
| 50 | Agammaglobulinemia (HP:0004432) | 2.78601789 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.78578880 |
| 52 | Eosinophilia (HP:0001880) | 2.77062854 |
| 53 | Abnormality of the prostate (HP:0008775) | 2.76653399 |
| 54 | Lymphopenia (HP:0001888) | 2.75518850 |
| 55 | Mitochondrial inheritance (HP:0001427) | 2.70407855 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.68874705 |
| 57 | Basal ganglia calcification (HP:0002135) | 2.68761452 |
| 58 | Chronic diarrhea (HP:0002028) | 2.65892474 |
| 59 | Cellulitis (HP:0100658) | 2.60894278 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.59876248 |
| 61 | Hepatocellular necrosis (HP:0001404) | 2.59365036 |
| 62 | Amyotrophic lateral sclerosis (HP:0007354) | 2.58853911 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.57259601 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.56410661 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.56106251 |
| 66 | Epistaxis (HP:0000421) | 2.55275642 |
| 67 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53556818 |
| 68 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53556818 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.48646092 |
| 70 | Recurrent pneumonia (HP:0006532) | 2.48587550 |
| 71 | Arterial thrombosis (HP:0004420) | 2.46768651 |
| 72 | Increased intramyocellular lipid droplets (HP:0012240) | 2.46449937 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.46425194 |
| 74 | Urticaria (HP:0001025) | 2.45113189 |
| 75 | Hepatosplenomegaly (HP:0001433) | 2.44361416 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 2.41345187 |
| 77 | Panhypogammaglobulinemia (HP:0003139) | 2.40739750 |
| 78 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.40147604 |
| 79 | Joint swelling (HP:0001386) | 2.39361677 |
| 80 | Hypoproteinemia (HP:0003075) | 2.39314433 |
| 81 | 3-Methylglutaconic aciduria (HP:0003535) | 2.38768469 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.37676123 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32999187 |
| 84 | Petechiae (HP:0000967) | 2.32651353 |
| 85 | Acute necrotizing encephalopathy (HP:0006965) | 2.32265779 |
| 86 | Granulocytopenia (HP:0001913) | 2.29271209 |
| 87 | Axonal loss (HP:0003447) | 2.24419351 |
| 88 | Recurrent sinusitis (HP:0011108) | 2.22970064 |
| 89 | IgA deficiency (HP:0002720) | 2.21647162 |
| 90 | Hepatic necrosis (HP:0002605) | 2.20770790 |
| 91 | Periodontitis (HP:0000704) | 2.20570506 |
| 92 | Increased muscle lipid content (HP:0009058) | 2.19308529 |
| 93 | Inflammation of the large intestine (HP:0002037) | 2.19117324 |
| 94 | Acute hepatic failure (HP:0006554) | 2.18444977 |
| 95 | Encephalitis (HP:0002383) | 2.18310321 |
| 96 | Skin rash (HP:0000988) | 2.15315312 |
| 97 | Increased IgE level (HP:0003212) | 2.15175058 |
| 98 | Pulmonary fibrosis (HP:0002206) | 2.15122964 |
| 99 | Lymphoma (HP:0002665) | 2.14737457 |
| 100 | Sepsis (HP:0100806) | 2.14699108 |
| 101 | Bronchitis (HP:0012387) | 2.14052554 |
| 102 | Hypertensive crisis (HP:0100735) | 2.11691694 |
| 103 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10777067 |
| 104 | Chronic sinusitis (HP:0011109) | 2.10187680 |
| 105 | Disinhibition (HP:0000734) | 2.09038238 |
| 106 | Skin ulcer (HP:0200042) | 2.09006133 |
| 107 | Increased CSF lactate (HP:0002490) | 2.06159120 |
| 108 | Abnormality of the pleura (HP:0002103) | 2.05271483 |
| 109 | Thrombocytosis (HP:0001894) | 2.04813362 |
| 110 | Dysostosis multiplex (HP:0000943) | 2.04388145 |
| 111 | Osteomyelitis (HP:0002754) | 2.04009281 |
| 112 | Gastrointestinal inflammation (HP:0004386) | 2.02577680 |
| 113 | Hematochezia (HP:0002573) | 2.02043570 |
| 114 | Arthralgia (HP:0002829) | 2.00529514 |
| 115 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.99937157 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 1.99937157 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99287431 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99287431 |
| 119 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99287431 |
| 120 | Prostate neoplasm (HP:0100787) | 1.98314410 |
| 121 | Papilloma (HP:0012740) | 1.97290237 |
| 122 | Verrucae (HP:0200043) | 1.97290237 |
| 123 | Pulmonary embolism (HP:0002204) | 1.96083440 |
| 124 | Cerebral palsy (HP:0100021) | 1.95340094 |
| 125 | Purpura (HP:0000979) | 1.93927434 |
| 126 | Emphysema (HP:0002097) | 1.93445235 |
| 127 | Chest pain (HP:0100749) | 1.91301225 |
| 128 | Vertebral compression fractures (HP:0002953) | 1.88234149 |
| 129 | B lymphocytopenia (HP:0010976) | 1.87676836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.76825298 |
| 2 | TXK | 3.65446681 |
| 3 | TESK1 | 3.61974990 |
| 4 | TESK2 | 3.56689204 |
| 5 | MAP3K14 | 3.27174042 |
| 6 | BLK | 3.07627231 |
| 7 | LIMK1 | 2.87799801 |
| 8 | TYK2 | 2.72017815 |
| 9 | MAP3K12 | 2.66343642 |
| 10 | TBK1 | 2.63111843 |
| 11 | JAK3 | 2.51602349 |
| 12 | VRK2 | 2.48264535 |
| 13 | ZAP70 | 2.42999215 |
| 14 | IKBKE | 2.32985730 |
| 15 | IRAK4 | 2.29977269 |
| 16 | KDR | 2.29501045 |
| 17 | RIPK4 | 2.26393362 |
| 18 | BCKDK | 2.12612815 |
| 19 | NME2 | 2.07359729 |
| 20 | MST4 | 1.97774439 |
| 21 | PIM2 | 1.87452727 |
| 22 | JAK1 | 1.85706957 |
| 23 | IKBKB | 1.80772432 |
| 24 | TAOK3 | 1.77924866 |
| 25 | SYK | 1.66176642 |
| 26 | ITK | 1.65560757 |
| 27 | MAP3K13 | 1.62916913 |
| 28 | CSK | 1.56031102 |
| 29 | LCK | 1.47825954 |
| 30 | ARAF | 1.46358073 |
| 31 | KIT | 1.43286871 |
| 32 | FGFR4 | 1.41232102 |
| 33 | STK10 | 1.37213306 |
| 34 | LRRK2 | 1.34411764 |
| 35 | GRK6 | 1.31520933 |
| 36 | TEC | 1.27437221 |
| 37 | HCK | 1.26028091 |
| 38 | BTK | 1.21182973 |
| 39 | NEK9 | 1.20135537 |
| 40 | EPHB1 | 1.18639812 |
| 41 | GRK5 | 1.17596208 |
| 42 | VRK1 | 1.16075141 |
| 43 | MAPKAPK3 | 1.05430649 |
| 44 | LYN | 1.03568721 |
| 45 | CSF1R | 1.03558057 |
| 46 | FGFR3 | 1.02665558 |
| 47 | TLK1 | 1.00333357 |
| 48 | FES | 0.98114599 |
| 49 | SIK3 | 0.94828809 |
| 50 | PRKCQ | 0.92942625 |
| 51 | MYLK | 0.92009343 |
| 52 | FGR | 0.91281817 |
| 53 | CHUK | 0.89940039 |
| 54 | TGFBR2 | 0.88917937 |
| 55 | MAP2K7 | 0.87963370 |
| 56 | ILK | 0.82983396 |
| 57 | PBK | 0.80531769 |
| 58 | EPHA3 | 0.76299408 |
| 59 | BMPR2 | 0.75453138 |
| 60 | JAK2 | 0.74331127 |
| 61 | MARK3 | 0.73889812 |
| 62 | CSNK1G3 | 0.72843952 |
| 63 | CAMKK2 | 0.71421286 |
| 64 | MAP4K2 | 0.71368994 |
| 65 | CLK1 | 0.71030789 |
| 66 | GRK7 | 0.70443864 |
| 67 | DAPK3 | 0.69660541 |
| 68 | STK16 | 0.68196480 |
| 69 | TNK2 | 0.66963671 |
| 70 | PIM1 | 0.66326385 |
| 71 | RPS6KA4 | 0.64892102 |
| 72 | KSR2 | 0.60922279 |
| 73 | PRKCD | 0.60805802 |
| 74 | FYN | 0.60609108 |
| 75 | SIK2 | 0.59109607 |
| 76 | IRAK3 | 0.59026540 |
| 77 | NLK | 0.57748768 |
| 78 | TAOK2 | 0.56208908 |
| 79 | CSNK1G2 | 0.50158039 |
| 80 | CSNK1A1L | 0.49859416 |
| 81 | MAPKAPK2 | 0.49484304 |
| 82 | PTK2B | 0.48286401 |
| 83 | IRAK1 | 0.47190985 |
| 84 | TRPM7 | 0.46526771 |
| 85 | DYRK2 | 0.46010813 |
| 86 | MAP3K5 | 0.44735604 |
| 87 | TIE1 | 0.44619297 |
| 88 | NUAK1 | 0.42523140 |
| 89 | ZAK | 0.42257995 |
| 90 | INSR | 0.41278534 |
| 91 | MAP3K11 | 0.39840388 |
| 92 | SRPK1 | 0.39190609 |
| 93 | PAK1 | 0.39092275 |
| 94 | MAP3K2 | 0.39079480 |
| 95 | MAPK13 | 0.38803554 |
| 96 | ABL1 | 0.38555441 |
| 97 | EGFR | 0.38289226 |
| 98 | PKN1 | 0.38188141 |
| 99 | PAK4 | 0.37117451 |
| 100 | BCR | 0.36698429 |
| 101 | MOS | 0.36125708 |
| 102 | PRPF4B | 0.35274163 |
| 103 | RAF1 | 0.35246922 |
| 104 | CDK19 | 0.34879438 |
| 105 | TTN | 0.34705436 |
| 106 | CSNK1G1 | 0.32055280 |
| 107 | ERBB3 | 0.31966229 |
| 108 | IGF1R | 0.31286942 |
| 109 | STK24 | 0.31269101 |
| 110 | ADRBK2 | 0.31218349 |
| 111 | MAPK11 | 0.30546987 |
| 112 | CAMKK1 | 0.30416384 |
| 113 | SRC | 0.28203878 |
| 114 | AURKA | 0.28135469 |
| 115 | MATK | 0.28008713 |
| 116 | BMPR1B | 0.27641767 |
| 117 | GRK1 | 0.27343390 |
| 118 | CDK14 | 0.26988341 |
| 119 | MAP2K6 | 0.26014643 |
| 120 | LMTK2 | 0.25435661 |
| 121 | ABL2 | 0.25241123 |
| 122 | DAPK1 | 0.25182754 |
| 123 | MAP3K1 | 0.24968729 |
| 124 | PRKCH | 0.24592376 |
| 125 | SCYL2 | 0.23001622 |
| 126 | STK4 | 0.20137543 |
| 127 | RPS6KA5 | 0.19023620 |
| 128 | MAP2K3 | 0.17968887 |
| 129 | ERN1 | 0.17885360 |
| 130 | PRKG2 | 0.17168239 |
| 131 | RET | 0.16453456 |
| 132 | PDGFRB | 0.16324554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.37073748 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.13075703 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.94665891 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70417235 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.57854542 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.34859546 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26455093 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24756193 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.13087281 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.08746437 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99104533 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.93997354 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90600370 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89338452 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.84737550 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81118319 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80799476 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79832695 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.78801043 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.78195608 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.72150082 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70338508 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.67774020 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.62038492 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61849572 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61355971 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59119916 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55185163 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.55080831 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.51303312 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44711253 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43934435 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43660085 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.43020407 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41226611 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.37790194 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36359049 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35412008 |
| 39 | Proteasome_Homo sapiens_hsa03050 | 1.34246710 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.32868946 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32138068 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29047045 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26053246 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.18477480 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14978099 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.14064276 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09673389 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03116213 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.99050370 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96758326 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92085322 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 0.89487555 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87695576 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87246316 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86992648 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85954606 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85807585 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85168277 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.83476283 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82971616 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80175947 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.76283504 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72602826 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.72248906 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71854042 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.71444741 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67640344 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66775848 |
| 69 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62337345 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61276367 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61137417 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58749033 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55985224 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55329664 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55322001 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54344952 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53727405 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.53402300 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52372939 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51270091 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50734308 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50274131 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50165790 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49833436 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.49217526 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46056587 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45830372 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43696399 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39582783 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37814700 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37207323 |
| 92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36539993 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35952016 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35225277 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35122719 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32176415 |
| 97 | DNA replication_Homo sapiens_hsa03030 | 0.31943448 |
| 98 | Phototransduction_Homo sapiens_hsa04744 | 0.30470208 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.29181185 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28836664 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.26757392 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.26605357 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26392158 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25969794 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25946578 |
| 106 | Focal adhesion_Homo sapiens_hsa04510 | 0.25190326 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.24663184 |
| 108 | Protein export_Homo sapiens_hsa03060 | 0.24122426 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22752889 |
| 110 | Peroxisome_Homo sapiens_hsa04146 | 0.22560443 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22556670 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22485172 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.20819053 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20331634 |
| 115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19254075 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18564939 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18436023 |
| 118 | Purine metabolism_Homo sapiens_hsa00230 | 0.15825439 |
| 119 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.14461865 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13989446 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13183305 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12171343 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.11410496 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.09509161 |
| 125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.08700859 |
| 126 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.08194535 |
| 127 | Spliceosome_Homo sapiens_hsa03040 | 0.06167357 |
| 128 | Homologous recombination_Homo sapiens_hsa03440 | 0.05643779 |

